Faecal microbiota from patients with cirrhosis has a low capacity to ferment non‐digestible carbohydrates into short‐chain fatty acids

Cirrhosis is associated with dysbiosis, but its functional consequences are still largely unknown. Short‐chain fatty acids (SCFAs) account for physiological interactions between the gut microbiota and host. Our aim was to assess the impact of cirrhotic dysbiosis on the production of SCFAs.

• Publication year

  2019

• Venue

  Liver international (Print)

• Publication date

  2019-08-01

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1111/liv.14106PMID 30919578
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Regulatory T Cells Restrict Permeability to Bacterial Antigen Translocation and Preserve Short‐Chain Fatty Acids in Experimental Cirrhosis

  2018cited by this paper
• Rifaximin has minor effects on bacterial composition, inflammation, and bacterial translocation in cirrhosis: A randomized trial

  2018cited by this paper
• Specific substrate-driven changes in human faecal microbiota composition contrast with functional redundancy in short-chain fatty acid production

  2017cited by this paper
• Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: A randomized clinical trial

  2017cited by this paper
• Continued Alcohol Misuse in Human Cirrhosis is Associated with an Impaired Gut–Liver Axis

  2017cited by this paper
• Targeting the gut-liver axis in liver disease.

  2017cited by this paper
• Microbial-Derived Butyrate Promotes Epithelial Barrier Function through IL-10 Receptor–Dependent Repression of Claudin-2

  2017cited by this paper
• High-Fiber Diet and Acetate Supplementation Change the Gut Microbiota and Prevent the Development of Hypertension and Heart Failure in Hypertensive Mice

  2017cited by this paper
• Associations between infant fungal and bacterial dysbiosis and childhood atopic wheeze in a nonindustrialized setting

  2017cited by this paper
• Changes in the Microbiome in Cirrhosis and Relationship to Complications: Hepatic Encephalopathy, Spontaneous Bacterial Peritonitis, and Sepsis

  2016cited by this paper
• The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota

  2016cited by this paper
• Rifaximin Exerts Beneficial Effects Independent of its Ability to Alter Microbiota Composition

  2016cited by this paper
• From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites.

  2016cited by this paper
• Precision medicine in alcoholic and nonalcoholic fatty liver disease via modulating the gut microbiota.

  2016cited by this paper
• Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity

  2016cited by this paper
• Fecal microbiota transplantation in the management of hepatic encephalopathy

  2016cited by this paper
• Crosstalk between Microbiota-Derived Short-Chain Fatty Acids and Intestinal Epithelial HIF Augments Tissue Barrier Function.

  2015cited by this paper
• Innovative and Emerging Technologies in GI Physiology and Disease Systems biology analysis of omeprazole therapy in cirrhosis demonstrates significant shifts in gut microbiota composition and function

  2014cited by this paper
• Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study Of Liver Diseases and the European Association for the Study of the Liver

  2014cited by this paper
• Altered profile of human gut microbiome is associated with cirrhosis and its complications.

  2014cited by this paper
• Functional gene arrays-based analysis of fecal microbiomes in patients with liver cirrhosis

  2014cited by this paper
• Phylogenetic distribution of three pathways for propionate production within the human gut microbiota

  2014cited by this paper
• Host-gut microbiota metabolic interactions

  2014cited by this paper
• Alterations of the human gut microbiome in liver cirrhosis

  2014cited by this paper
• The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic Treg Cell Homeostasis

  2013cited by this paper
• In vitro characterization of the impact of selected dietary fibers on fecal microbiota composition and short chain fatty acid production.

  2013cited by this paper
• Olfactory receptor responding to gut microbiota-derived signals plays a role in renin secretion and blood pressure regulation

  2013cited by this paper
• Modulation of the Metabiome by Rifaximin in Patients with Cirrhosis and Minimal Hepatic Encephalopathy

  2013cited by this paper
• Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation.

  2012cited by this paper
• Host-Gut Microbiota Metabolic Interactions

  2012cited by this paper
• In Vitro Digestion of RS4-Type Resistant Wheat and Potato Starches, and Fermentation of Indigestible Fractions

  2011cited by this paper
• Characterization of fecal microbial communities in patients with liver cirrhosis

  2011cited by this paper
• Short chain fatty acids exchange across the gut and liver in humans measured at surgery.

  2009cited by this paper
• Comparison of the in vitro bifidogenic properties of pectins and pectic‐oligosaccharides

  2002cited by this paper
• Effects of soluble corn bran arabinoxylans on cecal digestion, lipid metabolism, and mineral balance (Ca, Mg) in rats.

  1999cited by this paper
• Physiological effects of resistant starches on fecal bulk, short chain fatty acids, blood lipids and glycemic index.

  1998cited by this paper
• In vitro production of short-chain fatty acids by bacterial fermentation of dietary fiber compared with effects of those fibers on hepatic sterol synthesis in rats.

  1993cited by this paper
• Effect of lactitol and lactulose administration on the fecal flora in cirrhotic patients.

  1990cited by this paper
• Contribution of gut bacterial metabolism to human metabolic disease.

  1988cited by this paper
• Effect of human faecal inoculum on in vitro fermentation variables

  1987cited by this paper
• Acidifying enemas (lactitol and lactose) vs. nonacidifying enemas (tap water) to treat acute portal‐systemic encephalopathy: A double‐blind, randomized clinical trial

  1987cited by this paper

• Berberine Ameliorates DSS-Induced Colitis via Regulation of Mucosal Barrier Homeostasis and Mucin-Degrading Microbiota

  2026cites this paper
• Effects of Ligilactobacillus salivarius on the control of pullorum disease and cecal microbiota in red-feathered native chickens

  2026cites this paper
• Gut microbiome in biliary atresia

  2026cites this paper
• A Potential Central Hub of Histamine in the Microbiota–Gut–Joint Axis in Rheumatoid Arthritis: Mechanisms and Translational Implications

  2026cites this paper
• Linking Brain and Immune Transcriptomes to Gut-Derived Metabolites in Hepatic Encephalopathy: An Explorative Integrative Multi-Omics Approach

  2025cites this paper
• Hepatic Encephalopathy: Insights Into the Impact of Metabolic Precipitates

  2025cites this paper
• Potential role of gut bacteria in the development of hepatocellular carcinoma

  2025cites this paper
• The Role of Changes in the Proportion of Fecal Short-Chain Fatty Acids on the Severity of Hepatic Encephalopathy in Cirrhosis Patients.

  2025influential citation
• In vitro fermentation properties of Ecklonia cava subsp. stolonifera and Eisenia bicyclis as next-generation prebiotics

  2025cites this paper
• Baseline Fusobacterium Abundance Predicts Ustekinumab Response in Crohn's Disease: A Prospective Microbiome Cohort Study

  2025cites this paper
• Association between a low–carbohydrate diet and macronutrient intake with the gut microbiome, and their interaction with dyslipidemia among Korean adults

  2025cites this paper
• Alcohol-related liver disease disrupts bile acid synthesis and is associated with compensatory gut microbiota changes

  2025cites this paper
• Multi-omics analysis reveals gut microbiota-metabolite interactions and their association with liver function in autoimmune overlap syndrome

  2025cites this paper
• Integrated Metabolome and Microbiome Analysis Reveals the Regulatory Effects of Fermented Soybean Meal on the Gut Microbiota of Late Gestation

  2025cites this paper
• Temporal response patterns of human gut microbiota to dietary fiber

  2025cites this paper
• Fecal Butyrate and Deoxycholic Acid Concentrations Correlate With Mortality in Patients With Liver Disease

  2025cites this paper
• Gut microbiome composition in patients with liver cirrhosis with and without hepatic encephalopathy: A systematic review and meta-analysis

  2025cites this paper
• Short-chain fatty acids alleviate cholestatic liver injury by improving gut microbiota and bile acid metabolism.

  2025cites this paper
• Total darkness activated intestinal clock system and improved intestinal barrier function in growing rabbits

  2025cites this paper
• Safety and efficacy of a defined bacterial consortium, VE303, to treat HE

  2025cites this paper
• Cardiometabolic benefits of a non-industrialized-type diet are linked to gut microbiome modulation.

  2025cites this paper
• Associations between changes in the gut microbiota and liver cirrhosis: a systematic review and meta-analysis

  2025cites this paper
• A Systematic Review of Microbiota in Cirrhosis: A Change Towards a More Pathogenic Predisposition

  2025cites this paper
• Pulmonary Hypertension and the Gut Microbiome

  2024cites this paper
• Gut Microbiota as Emerging Players in the Development of Alcohol-Related Liver Disease

  2024cites this paper
• Heat-treated brown rice starch structure and effect on short-chain fatty acids and mouse intestinal microbiota.

  2024cites this paper
• Comparative Study of Gut Microbiota and Metabolite Variations Between Severe and Mild Acute Pancreatitis Patients at Different Stages.

  2024cites this paper
• Specific gut microbiome signatures predict the risk of acute ischemic stroke

  2024cites this paper
• Proton Pump Inhibitors and Oral–Gut Microbiota: From Mechanism to Clinical Significance

  2024cites this paper
• Potential mechanisms of traditional Chinese medicine in the treatment of liver cirrhosis: a focus on gut microbiota

  2024cites this paper
• Oral Yak Whey Protein Can Alleviate UV-Induced Skin Photoaging and Modulate Gut Microbiota Composition

  2024cites this paper
• Relationship between infant gastrointestinal microorganisms and maternal microbiome within 6 months of delivery

  2024cites this paper
• Impact of commercial gut health interventions on caecal metagenome and broiler performance

  2024cites this paper
• Effects of a Nutraceutical Treatment on the Intestinal Microbiota of Sled Dogs

  2024cites this paper
• The gut-liver axis in hepatobiliary diseases

  2024cites this paper
• Gut Bacteria in Alcohol-Associated Liver Disease.

  2024cites this paper
• Therapeutic manipulation of the microbiome in liver disease.

  2024cites this paper
• Isolation of mucosa-associated microbiota dysbiosis in the ascending colon in hepatitis C virus post-sustained virologic response cirrhotic patients

  2024cites this paper
• Vaccine Responses in Patients with Liver Cirrhosis: From the Immune System to the Gut Microbiota

  2024cites this paper
• An In Vitro Colonic Fermentation Study of the Effects of Human Milk Oligosaccharides on Gut Microbiota and Short-Chain Fatty Acid Production in Infants Aged 0–6 Months

  2024cites this paper
• Role of the gut microbiota in the pathogenesis of endometriosis: a review

  2024cites this paper
• Gut microbiome features and metabolites in non-alcoholic fatty liver disease among community-dwelling middle-aged and older adults

  2024cites this paper
• Short-chain fatty acids in nonalcoholic fatty liver disease: New prospects for short-chain fatty acids as therapeutic targets

  2024cites this paper
• Unveiling the connection between gut microbiome and metabolic health in individuals with chronic spinal cord injury.

  2024cites this paper
• Gut Microbiota and Biomarkers of Endothelial Dysfunction in Cirrhosis

  2024cites this paper
• Gut-Liver-Brain Axis and Alcohol Use Disorder: Treatment Potential of Fecal Microbiota Transplantation

  2024cites this paper
• Exploring the Relationship between Liver Disease, Bacterial Translocation, and Dysbiosis: Unveiling the Gut-Liver Axis

  2024cites this paper
• Causal Relationship Between Gut Microbiota and Liver Cirrhosis: 16S rRNA Sequencing and Mendelian Randomization Analyses

  2023cites this paper
• Factors associated with the composition of the gut microbiome in patients with established rheumatoid arthritis and its value for predicting treatment responses

  2023cites this paper
• Identification reproducible microbiota biomarkers for the diagnosis of cirrhosis and hepatocellular carcinoma

  2023cites this paper
• Gut microbiome as a therapeutic target for liver diseases.

  2023cites this paper
• Small Intestinal Bacterial Overgrowth Is Associated with Poor Prognosis in Cirrhosis

  2023cites this paper
• Gut–liver axis: barriers and functional circuits

  2023cites this paper
• Gut Dysbiosis and Blood-Brain Barrier Alteration in Hepatic Encephalopathy: From Gut to Brain

  2023cites this paper
• Effects of fish collagen on hairless mice skin photoaging induced by ultraviolet irradiation via regulation of the TGF- β signaling pathway

  2023cites this paper
• Efficacy of Biejiajian Pill on Intestinal Microbiota in Patients with Hepatitis B Cirrhosis/Liver Fibrosis: A Randomized Double-Blind Controlled Trial

  2023cites this paper
• The pathogenesis of gut microbiota in hepatic encephalopathy by the gut–liver–brain axis

  2023cites this paper
• Low diversity microbiota and an increased metabolism of arginine and aromatic amino acids: a hallmark of hepatic encephalopathy in western Mexican patients with alcohol-associated cirrhosis.

  2023cites this paper
• Targeting nonalcoholic fatty liver disease via gut microbiome-centered therapies

  2023cites this paper
• Alterations in the gut microbiota and the efficacy of adjuvant probiotic therapy in liver cirrhosis

  2023cites this paper
• Differences in Fecal Short-Chain Fatty Acids between Alcoholic Fatty Liver-Induced Cirrhosis and Non-alcoholic (Metabolic-Associated) Fatty Liver-Induced Cirrhosis

  2023cites this paper
• Auricularia auricula polysaccharides attenuate obesity in mice through gut commensal Papillibacter cinnamivorans

  2023cites this paper
• The Role of the Gastrointestinal Microbiome in Liver Disease

  2023cites this paper
• Gut Dysbiosis and Hemodynamic Changes as Links of the Pathogenesis of Complications of Cirrhosis

  2023cites this paper
• Pleiotropic prebiotic for liver disease

  2023cites this paper
• Baizhu‐Baishao herb pair ameliorates functional constipation and intestinal microflora disorder in rats

  2023cites this paper
• Gut Microbiota and Bacterial Translocation in the Pathogenesis of Liver Fibrosis

  2023cites this paper
• Sarcopenia in cirrhosis: Prospects for therapy targeted to gut microbiota

  2023cites this paper
• Application of Natural Biopolymersand its Derivatives as Nano -Drug Delivery Systems in Cancer Treatment

  2022cites this paper
• Dynamic changes of inulin utilization associated with longitudinal development of gut microbiota.

  2022cites this paper
• Comorbidity of functional bowel disorders and obesity in terms of microbiome

  2022cites this paper
• Effects of alfalfa levels on carcass traits, meat quality, fatty acid composition, amino acid profile, and gut microflora composition of Heigai pigs

  2022cites this paper
• Effect of feeding raw potato starch on the composition dynamics of the piglet intestinal microbiome

  2022cites this paper
• The Potential of Pectins to Modulate the Human Gut Microbiota Evaluated by In Vitro Fermentation: A Systematic Review

  2022cites this paper
• Dynamics of microbial communities during inulin fermentation associated with the temporal response in SCFA production.

  2022cites this paper
• Effect of probiotics on hemodynamic changes and complications associated with cirrhosis: A pilot randomized controlled trial

  2022cites this paper
• Co-fermented defatted rice bran alters gut microbiota and improves growth performance, antioxidant capacity, immune status and intestinal permeability of finishing pigs

  2022cites this paper
• Microbiota diversity in nonalcoholic fatty liver disease and in drug-induced liver injury.

  2022cites this paper
• A Class IIb Bacteriocin Plantaricin NC8 Modulates Gut Microbiota of Different Enterotypes in vitro

  2022cites this paper
• Gut dysbiosis and body composition in cirrhosis

  2022cites this paper
• Escherichia/Shigella, SCFAs, and Metabolic Pathways—The Triad That Orchestrates Intestinal Dysbiosis in Patients with Decompensated Alcoholic Cirrhosis from Western Mexico

  2022cites this paper
• Promises of microbiome-based therapies.

  2022cites this paper
• Elucidating the role of the gut microbiota in the physiological effects of dietary fiber

  2022cites this paper
• The Relationship between Intestinal Dysbacteriosis and Liver Cirrhosis

  2022cites this paper
• The Gut Microbiome and Metabolites Are Altered and Interrelated in Patients With Rheumatoid Arthritis

  2022cites this paper
• Altered gut microbiota and its association with inflammation in patients with chronic thromboembolic pulmonary hypertension: a single-center observational study in Japan

  2022cites this paper
• Effects of Short-Chain Fatty Acid Modulation on Potentially Diarrhea-Causing Pathogens in Yaks Through Metagenomic Sequencing

  2022cites this paper
• Gut dysbiosis and small intestinal bacterial overgrowth as independent forms of gut microbiota disorders in cirrhosis

  2022cites this paper
• Predicting butyrate- and propionate-forming bacteria of gut microbiota from sequencing data

  2022cites this paper
• Patients with low muscle mass have characteristic microbiome with low potential for amino acid synthesis in chronic liver disease

  2022cites this paper
• Association between gut colonization of vancomycin‐resistant enterococci and liver transplant outcomes

  2022cites this paper
• Adolescent autism and autoimmune diagnoses linked to infant gut bacteria whose prevalence is associated with at-risk genetics and/or diet

  2021cites this paper
• Gut Microbiota Exceeds Cervical Microbiota for Early Diagnosis of Endometriosis

  2021cites this paper
• The High Level of Xylooligosaccharides Improves Growth Performance in Weaned Piglets by Increasing Antioxidant Activity, Enhancing Immune Function, and Modulating Gut Microbiota

  2021cites this paper
• Gut Dysbiosis and Hemodynamic Changes as Links of the Pathogenesis of Complications of Cirrhosis

  2021cites this paper
• Gut-liver axis in cirrhosis: Are hemodynamic changes a missing link?

  2021cites this paper
• Glycated albumin as a biomarker for diagnosis of diabetes mellitus: A systematic review and meta-analysis

  2021cites this paper
• Deletion of intestinal SIRT1 exacerbated muscle wasting in cirrhotic mice by decreasing the intestinal concentration of short-chain fatty acids and inflammation.

  2021cites this paper
• The impact of the gut microbiome on liver transplantation

  2021cites this paper
• Digital Therapeutics Care Utilizing Genetic and Gut Microbiome Signals for the Management of Functional Gastrointestinal Disorders: Results From a Preliminary Retrospective Study

  2021cites this paper